Skip to main content

Articles

Page 40 of 62

  1. Diabetes mellitus (DM) is estimated to become the 7th leading cause of death by 2030. Right ventricular dysfunction (RVD) complicating ST elevation myocardial infarction (STEMI) is independently associated wit...

    Authors: Idan Roifman, Nilesh Ghugre, Mohammad I. Zia, Michael E. Farkouh, Anna Zavodni, Graham A. Wright and Kim A. Connelly
    Citation: Cardiovascular Diabetology 2016 15:34
    Content type: Original investigation Published on:

  2. The 1st Cardiovascular Outcome Trial (CVOT) Summit of the Diabetes & Cardiovascular Disease (D&CVD) EASD Study Group was held during the annual meeting on 30 October 2015 in Munich. This summit was organized i...

    Authors: Oliver Schnell, Eberhard Standl, Doina Catrinoiu, Stefano Genovese, Nebojsa Lalic, Jan Skra, Paul Valensi and Antonio Ceriello
    Citation: Cardiovascular Diabetology 2016 15:33
    Content type: Commentary Published on:

  3. Adenosine has been shown to induce nitric oxide (NO) production via inducible NO synthase (iNOS) activation in vascular smooth muscle cells (VSMCs). Although this is interpreted as a beneficial vasodilating pa...

    Authors: Alberto Nassi, Francesca Malorgio, Serena Tedesco, Andrea Cignarella and Rosa Maria Gaion
    Citation: Cardiovascular Diabetology 2016 15:32
    Content type: Original investigation Published on:

  4. Children with type 1 diabetes (T1D) are at higher risk of early adult-onset cardiovascular disease. We assessed cardiovascular structure and function in adolescents with T1D compared with healthy controls and ...

    Authors: Timothy J. Bradley, Cameron Slorach, Farid H. Mahmud, David B. Dunger, John Deanfield, Livia Deda, Yesmino Elia, Ronnie L. H. Har, Wei Hui, Rahim Moineddin, Heather N. Reich, James W. Scholey, Luc Mertens, Etienne Sochett and David Z. I. Cherney
    Citation: Cardiovascular Diabetology 2016 15:31
    Content type: Original Investigation Published on:

  5. Skin collagen Long Wavelength Fluorescence (LWF) is widely used as a surrogate marker for accumulation of advanced glycation end-products. Here we determined the relationship of LWF with glycemia, skin fluores...

    Authors: David R. Sell, Wanjie Sun, Xiaoyu Gao, Christopher Strauch, John M. Lachin, Patricia A. Cleary, Saul Genuth and Vincent M. Monnier
    Citation: Cardiovascular Diabetology 2016 15:30
    Content type: Original investigation Published on:

  6. Epidemiological data on obesity are needed, particularly in patients with type 2 diabetes mellitus (T2DM) and high cardiovascular (CV) risk. We used the baseline data of liraglutide effect and action in diabet...

    Authors: L. Masmiquel, L. A. Leiter, J. Vidal, S. Bain, J. Petrie, E. Franek, I. Raz, A. Comlekci, S. Jacob, L. van Gaal, F. M. M. Baeres, S. P. Marso and M. Eriksson
    Citation: Cardiovascular Diabetology 2016 15:29
    Content type: Original Investigation Published on:

  7. There is increasing evidence to suggest that not all individuals with type 2 diabetes mellitus (T2DM) have equal risk for developing cardiovascular disease. We sought to compare the yield of testing for pre-cl...

    Authors: Carlos Henrique Reis Esselin Rassi, Timothy W. Churchill, Carlos A. Fernandes Tavares, Mateus Guimaraes Fahel, Fabricia P. O. Rassi, Augusto H. Uchida, Bernardo L. Wajchenberg, Antonio C. Lerario, Edward Hulten, Khurram Nasir, Márcio S. Bittencourt, Carlos Eduardo Rochitte and Ron Blankstein
    Citation: Cardiovascular Diabetology 2016 15:28
    Content type: Original investigation Published on:

  8. Cardiovascular disease (CVD) is the leading cause of morbidity and mortality in patients with diabetes mellitus (DM). To identify the most effective treatment for CVD, it is paramount to understand the mechani...

    Authors: Sherin Bakhashab, Fahad W. Ahmed, Hans-Juergen Schulten, Ayat Bashir, Sajjad Karim, Abdulrahman L. Al-Malki, Mamdooh A. Gari, Adel M. Abuzenadah, Adeel G. Chaudhary, Mohammed H. Alqahtani, Sahira Lary, Farid Ahmed and Jolanta U. Weaver
    Citation: Cardiovascular Diabetology 2016 15:27
    Content type: Original investigation Published on:

  9. Diabetes is a risk factor for atherosclerosis associated with oxidative stress, inflammation and cell proliferation. The purpose of this study was to evaluate arterial choline uptake and its relationship to at...

    Authors: Sanna Hellberg, Johanna M. U. Silvola, Max Kiugel, Heidi Liljenbäck, Olli Metsälä, Tapio Viljanen, Jari Metso, Matti Jauhiainen, Pekka Saukko, Pirjo Nuutila, Seppo Ylä-Herttuala, Juhani Knuuti, Anne Roivainen and Antti Saraste
    Citation: Cardiovascular Diabetology 2016 15:26
    Content type: Original investigation Published on:

  10. ANGPTL8 also called betatrophin is a regulator of lipid metabolism through its interaction with ANGPTL3. It has also been suggested to play a role in insulin resistance and beta-cell proliferation. Based on it...

    Authors: Mohamed Abu-Farha, Jehad Abubaker, Irina Al-Khairi, Preethi Cherian, Fiona Noronha, Sina Kavalakatt, Abdelkrim Khadir, Kazem Behbehani, Monira Alarouj, Abdullah Bennakhi and Naser Elkum
    Citation: Cardiovascular Diabetology 2016 15:25
    Content type: Original investigation Published on:

  11. A novel MRI technique, employing dual contrast manganese-enhanced MRI (MEMRI) and delayed enhancement MRI (DEMRI), can evaluate the physiologically unstable peri-infarct region. Dual contrast MEMRI–DEMRI enab...

    Authors: Ildiko Toma, Paul J. Kim, Rajesh Dash, Michael V. McConnell, Dwight Nishimura, Phillip Harnish and Phillip C. Yang
    Citation: Cardiovascular Diabetology 2016 15:24
    Content type: Original investigation Published on:

  12. Gestational diabetes mellitus (GDM) is a significant risk factor for cardiovascular disease (CVD) in later life. Pentraxin 3 (PTX3) is an essential component of innate immunity and independently associated wit...

    Authors: Tove Lekva, Annika Elisabeth Michelsen, Jens Bollerslev, Errol R. Norwitz, Pål Aukrust, Tore Henriksen and Thor Ueland
    Citation: Cardiovascular Diabetology 2016 15:23
    Content type: Original investigation Published on:

  13. Patients with type 2 diabetes mellitus (T2DM) are at high risk for cardiovascular events. The aim of the study was to assess whether global longitudinal strain (GLS) provides prognostic value in these patients.

    Authors: Ju-Hua Liu, Yan Chen, Michele Yuen, Zhe Zhen, Carmen Wing-Sze Chan, Karen Siu-Ling Lam, Hung-Fat Tse and Kai-Hang Yiu
    Citation: Cardiovascular Diabetology 2016 15:22
    Content type: Original investigation Published on:

  14. Glucagon-like peptide-1 (GLP-1) is an incretin hormone, which gets secreted in response to nutritional stimuli from the gut mediating glucose-dependent insulin secretion. Interestingly, GLP-1 was recently foun...

    Authors: Corinna Lebherz, Florian Kahles, Katja Piotrowski, Michael Vogeser, Ann Christina Foldenauer, Kirsten Nassau, Erich Kilger, Nikolaus Marx, Klaus G. Parhofer and Michael Lehrke
    Citation: Cardiovascular Diabetology 2016 15:21
    Content type: Original Investigation Published on:

  15. The genetic contribution to complex diseases or traits, including cardio-metabolic traits, has been elucidated recently by large-scale genome-wide association studies. These genome-wide association studies hav...

    Authors: Yun Kyoung Kim, Mi Yeong Hwang, Young Jin Kim, Sanghoon Moon, Sohee Han and Bong-Jo Kim
    Citation: Cardiovascular Diabetology 2016 15:20
    Content type: Original investigation Published on:

  16. Abnormalities in lipid and glucose metabolism are constantly observed in type 2 diabetes. However, these abnormalities can be ameliorated by polydatin. Considering the important role of proprotein convertase s...

    Authors: Yu Wang, Jiantao Ye, Jie Li, Cheng Chen, Junying Huang, Peiqing Liu and Heqing Huang
    Citation: Cardiovascular Diabetology 2016 15:19
    Content type: Original investigation Published on:

  17. We tested the hypothesis that glucose-induced hyperosmolarity, occurring in diabetic hyperglycemia, promotes retinal angiogenesis, and that interference with osmolarity signaling ameliorates excessive angiogen...

    Authors: Rosalinda Madonna, Gaia Giovannelli, Pamela Confalone, Francesca Vera Renna, Yong-Jian Geng and Raffaele De Caterina
    Citation: Cardiovascular Diabetology 2016 15:18
    Content type: Original investigation Published on:

  18. Despite its beneficial role on insulin resistance and atherosclerosis, adiponectin has been repeatedly reported as an independent positive predictor of cardiovascular mortality.

    Authors: Lorena Ortega Moreno, Massimiliano Copetti, Andrea Fontana, Concetta De Bonis, Lucia Salvemini, Vincenzo Trischitta and Claudia Menzaghi
    Citation: Cardiovascular Diabetology 2016 15:17
    Content type: Original Investigation Published on:

  19. Both uremia and metabolic syndrome (MetS) affect heart rate variability (HRV) which is a risk factor of poor prognoses. The aim of this study was to evaluate the impact of MetS on HRV among chronic hemodialysi...

    Authors: Yu-Ming Chang, Chih-Chung Shiao, Ya-Ting Huang, I-Ling Chen, Chuan-Lan Yang, Show-Chin Leu, Hung-Li Su, Jsun-Liang Kao, Shih-Ching Tsai, Rong-Na Jhen and Ching-Cherng Uen
    Citation: Cardiovascular Diabetology 2016 15:16
    Content type: Original investigation Published on:

    The Erratum to this article has been published in Cardiovascular Diabetology 2017 16:90

  20. The effect of gestational diabetes mellitus (GDM) on cardiovascular diseases (CVD) is not assessed within the first 10 years postpartum, regardless of subsequent diabetes. The aim of this study was to determin...

    Authors: Karine Goueslard, Jonathan Cottenet, Anne-Sophie Mariet, Maurice Giroud, Yves Cottin, Jean-Michel Petit and Catherine Quantin
    Citation: Cardiovascular Diabetology 2016 15:15
    Content type: Original investigation Published on:

  21. Older patients with longstanding type 1 diabetes have high cardiovascular disease (CVD) risk such that statin therapy is recommended independent of prior CVD events. We aimed to determine self-reported CVD pr...

    Authors: Johnny W. Bai, Geneviève Boulet, Elise M. Halpern, Leif E. Lovblom, Devrim Eldelekli, Hillary A. Keenan, Michael Brent, Narinder Paul, Vera Bril, David Z. I. Cherney, Alanna Weisman and Bruce A. Perkins
    Citation: Cardiovascular Diabetology 2016 15:14
    Content type: Original investigation Published on:

  22. Carotid intima-media thickness (cIMT) holds prognostic information for future cardiovascular disease and is associated with the extent of coronary atherosclerosis. We investigated the effect of exercise on cIM...

    Authors: Rune Byrkjeland, Knut-Haakon Stensæth, Sigmund Anderssen, Ida U. Njerve, Harald Arnesen, Ingebjørg Seljeflot and Svein Solheim
    Citation: Cardiovascular Diabetology 2016 15:13
    Content type: Original investigation Published on:

  23. Lipoprotein-related mechanisms have been associated with damage to the cardiovascular system in diabetic patients. Apolipoprotein E gene which affects the clearance of lipoproteins and consequently the lipid p...

    Authors: Dalia El-Lebedy, Hala M. Raslan and Asmaa M. Mohammed
    Citation: Cardiovascular Diabetology 2016 15:12
    Content type: Original investigation Published on:

    The Erratum to this article has been published in Cardiovascular Diabetology 2016 15:35

  24. Recent data support the renewed interest in hypertriglyceridemia as a possible important therapeutic target for cardiovascular risk reduction. This study was designed to address the question of all-cause morta...

    Authors: Yaron Arbel, Robert Klempfner, Aharon Erez, Ilan Goldenberg, Sagit Benzekry, Nir Shlomo, Enrique Z. Fisman and Alexander Tenenbaum
    Citation: Cardiovascular Diabetology 2016 15:11
    Content type: Original investigation Published on:

  25. We aimed to investigate whether visceral adiposity could modify the impact of blood pressure on arterial stiffness and albuminuria in patients with type 2 diabetes.

    Authors: Ryotaro Bouchi, Norihiko Ohara, Masahiro Asakawa, Yujiro Nakano, Takato Takeuchi, Masanori Murakami, Yuriko Sasahara, Mitsuyuki Numasawa, Isao Minami, Hajime Izumiyama, Koshi Hashimoto, Takanobu Yoshimoto and Yoshihiro Ogawa
    Citation: Cardiovascular Diabetology 2016 15:10
    Content type: Original investigation Published on:

  26. The aims of this study were to investigate whether circulating irisin is associated with favorable metabolic parameters and how the association differs according to body composition in humans.

    Authors: You-Cheol Hwang, Won Seon Jeon, Cheol-Young Park and Byung-Soo Youn
    Citation: Cardiovascular Diabetology 2016 15:9
    Content type: Original Investigation Published on:

  27. Hypertension is a multi-factorial disease of increasing prevalence and a major risk factor for cardiovascular mortality even in the presence of adequate treatment. Progression of cardiovascular disease (CVD) o...

    Authors: Laura Gonzalez-Calero, Marta Martin-Lorenzo, Fernando de la Cuesta, Aroa S. Maroto, Montserrat Baldan-Martin, Gema Ruiz-Hurtado, Helena Pulido-Olmo, Julian Segura, Maria G. Barderas, Luis M. Ruilope, Fernando Vivanco and Gloria Alvarez-Llamas
    Citation: Cardiovascular Diabetology 2016 15:8
    Content type: Original investigation Published on:

  28. The prevention of cardiovascular disease, including diastolic cardiac dysfunction with its high prevalence and ominous prognosis, is a therapeutic challenge for patients with type 2 diabetes. Both short and lo...

    Authors: Helene von Bibra, Thorsten Siegmund, Iris Kingreen, Markus Riemer, Tibor Schuster and Petra-Maria Schumm-Draeger
    Citation: Cardiovascular Diabetology 2016 15:7
    Content type: Original investigation Published on:

  29. Platelet hyper-reactivity is a crucial cause of accelerated atherosclerosis increasing risk of thrombotic vascular events in diabetic patients. The mechanisms leading to abnormal platelet activity during diab...

    Authors: Wenqing Wang, Wayne Bond Lau, Yajing Wang, Xinliang Ma and Rong Li
    Citation: Cardiovascular Diabetology 2016 15:6
    Content type: Original investigation Published on:

  30. We evaluated the risks of renal and cardiovascular complications, and mortality associated with lower extremity amputation (LEA) in patients with type 1 diabetes.

    Authors: Kamel Mohammedi, Louis Potier, Narimène Belhatem, Nadia Matallah, Samy Hadjadj, Ronan Roussel, Michel Marre and Gilberto Velho
    Citation: Cardiovascular Diabetology 2016 15:5
    Content type: Original investigation Published on:

  31. Circadian rhythms regulate key biological processes influencing metabolic pathways. Disregulation is associated with type 2 diabetes (T2D) and cardiovascular diseases (CVD). Circadian rhythms are generated by...

    Authors: Dolores Corella, Eva. M. Asensio, Oscar Coltell, José V. Sorlí, Ramón Estruch, Miguel Ángel Martínez-González, Jordi Salas-Salvadó, Olga Castañer, Fernando Arós, José Lapetra, Lluís Serra-Majem, Enrique Gómez-Gracia, Carolina Ortega-Azorín, Miquel Fiol, Javier Díez Espino, Andrés Díaz-López…
    Citation: Cardiovascular Diabetology 2016 15:4
    Content type: Original investigation Published on:

  32. Betatrophin is a newly identified liver-derived hormone that is associated with glucose homeostasis and lipid metabolism. Although dysregulated lipid metabolism results in diabetic nephropathy (DN) development...

    Authors: Chang-Chiang Chen, Hendra Susanto, Wen-Han Chuang, Ta-Yu Liu and Chih-Hong Wang
    Citation: Cardiovascular Diabetology 2016 15:3
    Content type: Original investigation Published on:

    The Erratum to this article has been published in Cardiovascular Diabetology 2017 16:58

  33. Data regarding the long-term clinical outcomes in patients with insulin-treated type 2 diabetes mellitus (ITDM) revascularized by either coronary artery bypass surgery (CABG) or percutaneous coronary intervent...

    Authors: Pravesh Kumar Bundhun, Zi Jia Wu and Meng-Hua Chen
    Citation: Cardiovascular Diabetology 2016 15:2
    Content type: Original investigation Published on:

  34. Previous studies have shown that angiopoietin-like protein 8 (ANGPTL8), also called as betatrophin, acts together with ANGPTL3 to regulate lipid metabolism, glucose metabolism, and energy homeostasis. Moreover...

    Authors: Hye Soo Chung, Min Jung Lee, Soon Young Hwang, Hyun Jung Lee, Hye Jin Yoo, Ji-A Seo, Sin Gon Kim, Nan Hee Kim, Sei Hyun Baik, Dong Seop Choi, Seon Mi Kim and Kyung Mook Choi
    Citation: Cardiovascular Diabetology 2016 15:1
    Content type: Original investigation Published on:

  35. To investigate the long-term efficacy and safety of empagliflozin monotherapy compared with placebo and sitagliptin in drug-naïve patients with type 2 diabetes mellitus.

    Authors: Michael Roden, Ludwig Merker, Anita Vedel Christiansen, Flavien Roux, Afshin Salsali, Gabriel Kim, Peter Stella, Hans J. Woerle and Uli C. Broedl
    Citation: Cardiovascular Diabetology 2015 14:154
    Content type: Original Investigation Published on:

  36. States of hyperinsulinemia, particularly insulin resistance and type 2 diabetes mellitus, are becoming remarkably common, with roughly half a billion people likely to suffer from the disorder within the next 1...

    Authors: Aimee E. Hodson, Trevor S. Tippetts and Benjamin T. Bikman
    Citation: Cardiovascular Diabetology 2015 14:153
    Content type: Original investigation Published on:

  37. To determine temporal changes in the prevalence and associates of lower extremity amputation (LEA) complicating type 2 diabetes.

    Authors: Mendel Baba, Wendy A. Davis, Paul E. Norman and Timothy M. E. Davis
    Citation: Cardiovascular Diabetology 2015 14:152
    Content type: Original investigation Published on:

  38. Remote ischemic perconditioning (RIPerC) has a promising therapeutic insight to improve the prognosis of acute myocardial infarction. Chronic comorbidities such as diabetes are known to interfere with conditio...

    Authors: Tamás Baranyai, Csilla Terézia Nagy, Gábor Koncsos, Zsófia Onódi, Melinda Károlyi-Szabó, András Makkos, Zoltán V. Varga, Péter Ferdinandy and Zoltán Giricz
    Citation: Cardiovascular Diabetology 2015 14:151
    Content type: Original investigation Published on:

  39. It remains to be established if, and to what extent, the coronary microcirculation becomes compromised during the development of obesity and insulin resistance. Recent studies suggest that changes in endotheli...

    Authors: Judith van Haare, M. Eline Kooi, Hans Vink, Mark J. Post, Jurgen W. G. E. van Teeffelen, Jos Slenter, Chantal Munts, Hanneke Cobelens, Gustav J. Strijkers, Dennis Koehn and Marc van Bilsen
    Citation: Cardiovascular Diabetology 2015 14:150
    Content type: Original investigation Published on:

    The Correction to this article has been published in Cardiovascular Diabetology 2021 20:51

  40. The effects of streptozotocin (STZ)-induced diabetes on heart metabolism and function after myocardial infarction (MI) remodelling were investigated in rats.

    Authors: Christiane Malfitano, Alcione Lescano de Souza Junior, Mariana Carbonaro, Andressa Bolsoni-Lopes, Diego Figueroa, Leandro Ezequiel de Souza, Kleiton Augusto Santos Silva, Fernanda Consolim-Colombo, Rui Curi and Maria Claudia Irigoyen
    Citation: Cardiovascular Diabetology 2015 14:149
    Content type: Original investigation Published on:

  41. The heart requires constant sources of energy mostly from free fatty acids (FFA) and glucose. The alteration in myocardial substrate metabolism occurs in the heart of diabetic patients, but its specific associ...

    Authors: Gyuri Kim, Kwanhyeong Jo, Kwang Joon Kim, Yong-ho Lee, Eugene Han, Hye-jin Yoon, Hye Jin Wang, Eun Seok Kang and Mijin Yun
    Citation: Cardiovascular Diabetology 2015 14:148
    Content type: Original investigation Published on:

  42. Few studies have investigated the association between coronary artery calcium (CAC) progression and arterial stiffness measured by brachial-ankle pulse wave velocity (baPWV). We examined the influence of the s...

    Authors: Jong-Young Lee, Seungho Ryu, Sung Ho Lee, Byung Jin Kim, Bum-Soo Kim, Jin-Ho Kang, Eun Sun Cheong, Jang-Young Kim, Jeong Bae Park and Ki-Chul Sung
    Citation: Cardiovascular Diabetology 2015 14:147
    Content type: Original investigation Published on:

  43. Type 2 diabetes mellitus is an important risk factor in the development of coronary artery disease (CAD) and is often associated with severe disease. However, this risk is not uniform, some patients remain fre...

    Authors: Mukund P. Srinivasan, Padmanabh K. Kamath, Narayan M. Bhat, Narasimha D. Pai, Poornima A. Manjrekar and Chakrapani Mahabala
    Citation: Cardiovascular Diabetology 2015 14:146
    Content type: Original investigation Published on:

  44. Diabetes mellitus (DM) leads to the development of diabetic cardiomyopathy, which is associated with altered nitric oxide (NO)—soluble guanylate cyclase (sGC)—cyclic guanosine monophosphate (cGMP) signalling. ...

    Authors: Csaba Mátyás, Balázs Tamás Németh, Attila Oláh, László Hidi, Ede Birtalan, Dalma Kellermayer, Mihály Ruppert, Sevil Korkmaz-Icöz, Gábor Kökény, Eszter Mária Horváth, Gábor Szabó, Béla Merkely and Tamás Radovits
    Citation: Cardiovascular Diabetology 2015 14:145
    Content type: Original investigation Published on:

  45. We aimed to determine the association between nonalcoholic fatty liver disease (NAFLD) and diabetes risk among body size phenotypes which was based on cross-classification of body mass index (BMI) categories (...

    Authors: Tingting Du, Xuefeng Yu, Gang Yuan, Jianhua Zhang and Xingxing Sun
    Citation: Cardiovascular Diabetology 2015 14:144
    Content type: Original investigation Published on:

  46. Diabetic patients are more sensitive to myocardial ischemic injury than non-diabetic patients. Silent information regulator 1 (SIRT1) is a nicotinamide adenine dinucleotide-dependent histone deacetylase making...

    Authors: Mingge Ding, Jingyi Lei, Hongcheng Han, Weibo Li, Yinxian Qu, Enqing Fu, Feng Fu and Xiaoming Wang
    Citation: Cardiovascular Diabetology 2015 14:143
    Content type: Original investigation Published on:

  47. Although antidiabetic agents have been developed to target one or more of the core defects of type 2 diabetes mellitus (T2DM), many patients do not achieve glycemic goals. Inhibition of the sodium-glucose cotr...

    Authors: Paola Fioretto, Andrea Giaccari and Giorgio Sesti
    Citation: Cardiovascular Diabetology 2015 14:142
    Content type: Review Published on:

  48. After acute myocardial infarction (AMI), the replicated phenomenon of obesity paradox, i.e., obesity appearing to be associated with increased survival, has not been evaluated in stabilized (i.e., without clin...

    Authors: Ki-Bum Won, Seung-Ho Hur, Yun-Kyeong Cho, Hyuck-Jun Yoon, Chang-Wook Nam, Kwon-Bae Kim, Jang-Ho Bae, Dong-Ju Choi, Young-Keun Ahn, Jong-Seon Park, Hyo-Soo Kim, Rak-Kyeong Choi, Donghoon Choi, Joon-Hong Kim, Kyoo-Rok Han, Hun-Sik Park…
    Citation: Cardiovascular Diabetology 2015 14:141
    Content type: Original investigation Published on:

    The Correction to this article has been published in Cardiovascular Diabetology 2023 22:159

  49. Whereas a few studies have reported associations of serum omentin levels with subclinical atherosclerosis in patients with diabetes, little information is available with respect to the associations of serum om...

    Authors: Chan-Hee Jung, Sang-Hee Jung, Bo-Yeon Kim, Chul-Hee Kim, Sung-Koo Kang and Ji-Oh Mok
    Citation: Cardiovascular Diabetology 2015 14:140
    Content type: Original investigation Published on:

  50. The object of this study was to investigate the potential role of FGF23 on plaque stability in type 2 diabetic patients with internal carotid artery stenosis.

    Authors: Federico Biscetti, Giuseppe Straface, Carlo Filippo Porreca, Giovanni Bertoletti, Claudio Vincenzoni, Francesco Snider, Egidio Stigliano, Vincenzo Arena, Flavia Angelini, Giovanni Pecorini, Antonio Bianchi, Raffaele Landolfi and Andrea Flex
    Citation: Cardiovascular Diabetology 2015 14:139
    Content type: Original investigation Published on:
journal logo

Cardiovascular Diabetology is affiliated with Sackler Faculty of Medicine, Tel-Aviv University

New Content Item

Submit manuscript

Annual Journal Metrics

  • Citation Impact 2023
    Journal Impact Factor: 8.5
    5-year Journal Impact Factor: 8.9
    Source Normalized Impact per Paper (SNIP): 1.855
    SCImago Journal Rank (SJR): 2.621

    Speed 2023
    Submission to first editorial decision (median days): 2
    Submission to acceptance (median days): 56

    Usage 2023
    Downloads: 2,523,778
    Altmetric mentions: 3,115

Cardiovascular Diabetology

ISSN: 1475-2840